Trial intelligence / Profile preview

Vaginal or Transdermal Testosterone for Postmenopausal Sexual Dysfunction

NCT06794346Phase 2Active, not recruiting

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Oct 2020
Primary completion
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Testosterone TEPI patch in female sexual dysfunction (FSD), menopause, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Oct 2020; status: active, not recruiting.

02

Drugs

Testosterone TEPI patch
03

Conditions

female sexual dysfunction (FSD)menopause

Beyond the preview

Go deeper on NCT06794346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06794346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call